IP Library Granted Patent US 8,962,023
Granted Patent B2
US 8,962,023 · App. 11/236,943 · Granted Feb 24, 2015

UV cured gel and method of making

Inventors: Roger Labrecque (Londonderry, NH); Philip McNamara (Concord, NH); Joseph Ferraro (Londonderry, NH); Lisa Rogers (Londonderry, NH); Paul Martakos (Pelham, NH); Theodore Karwoski (Hollis, NH); Steve A. Herweck (Nashua, NH); Keith Faucher (Nashua, NH); Thomas M. Swanick (Hillsborough, NH)
Assignee: Atrium Medical Corporation
A61L27/54A61F13/02A61F13/023A61K9/0024A61K9/06A61K31/225A61K31/355A61K47/12A61K47/14A61L2/07A61L2/081A61L2/087A61L2/206A61L2/208A61L27/36A61L27/52A61L31/005A61L31/10A61L31/145A61F2/06A61F2250/0067A61L2202/24A61L2300/22A61L2300/252A61L2300/404A61L2300/41A61L2300/414A61L2300/42A61L2300/602B05D3/067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,962,023
App. No.
11/236,943
Granted
Feb 24, 2015
Kind
B2
Abstract

A method of UV curing and corresponding resulting non-polymeric cross-linked gel are provided. The cross-linked gel can be combined with a medical device structure. The cross-linked gel can provide anti-adhesion characteristics, in addition to improved healing and anti-inflammatory response. The cross-linked gel is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel derived from at least one fatty acid compound. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent. The curing method can vary the application of UV light in both intensity and duration to achieve a desired amount of cross-linking forming the gel.

Claims (30)

1. An ultraviolet (UV) light cured gel, the gel comprising:

fish oil, wherein the fish oil comprises unsaturated fatty acids;

wherein the fish oil is in a state of having been cured by application of UV light to cross link the unsaturated fatty acids by ester bonds in a substantially random configuration to form the gel;

wherein the gel is bioabsorbable;

wherein the gel further comprises a therapeutic agent; and

wherein the amount of curing is controlled by the application of the UV light in such a way that the gel is configured to provide controlled release of the therapeutic agent.

2. An ultraviolet (UV) light cured gel, the gel comprising:

fish oil, wherein the fish oil comprises unsaturated fatty acids;

wherein the fish oil is in a state of having been cured by application of UV light to cross link the unsaturated fatty acids by ester bonds in a substantially random configuration to form the gel;

wherein the gel is bioabsorbable;

wherein the gel further comprises a therapeutic agent; and

wherein following implantation of the gel in a patient, the gel degrades and thereby releases the therapeutic agent.

3. The gel of claim 2 , wherein the fish oil comprises at least a partially cured oil or oil composition.

4. The gel of claim 2 , wherein the gel is configured to release the therapeutic agent over at least about seven days following implantation.

5. The gel of claim 4 , wherein the gel is formed with application of UV light at 252 nm.

6. The gel of claim 4 , wherein the gel is formed with application of UV light for 48 hours.

7. The gel of claim 4 , wherein the gel is formed with application of UV light at 252 nm for 48 hours.

8. The gel of claim 2 , wherein the gel is configured to provide controlled release of the therapeutic agent.

9. The gel of claim 2 , wherein the gel exhibits at least one property selected from the group consisting of anti-inflammatory properties, non-inflammatory properties, and wound healing properties.

10. The gel of claim 2 , wherein the gel has been sterilized with a method of sterilization selected from the group of methods of sterilization consisting of ethylene oxide, gamma radiation, e-beam, steam, gas plasma, and vaporized hydrogen peroxide (VHP).

11. The gel of claim 2 , wherein the gel is configured as a coating on a medical device or as a stand-alone film.

12. The gel of claim 2 , wherein the fish oil is pre-treated to increase viscosity prior to curing.

13. The gel of claim 2 , further comprising vitamin E.

14. An ultraviolet (UV) light cured gel, the gel comprising:

fish oil, wherein the fish oil comprises unsaturated fatty acids;

wherein the fish oil is in a state of having been cured by application of UV light to cross link the unsaturated fatty acids by ester bonds in a substantially random configuration to form the gel;

wherein the gel is bioabsorbable;

wherein the gel further comprises an anti-proliferative agent; and

wherein following placement of the gel in a 0.01M PBS solution, the gel degrades and thereby releases the anti-proliferative agent.

15. The gel of claim 2 , wherein the therapeutic agent is selected from the group consisting of antioxidants, anti-inflammatory agents, anti-coagulant agents, drugs to alter lipid metabolism, anti-proliferatives, anti-neoplastics, tissue growth stimulants, functional proteins, anti-infective agents, imaging agents, anesthetic agents, chemotherapeutic agents, tissue absorption enhancers, anti-adhesion agents, germicides, analgesics, and antiseptics.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2005
From: LABRECQUE, ROGER; MCNAMARA, PHILIP; FERRARO, JOSEPH; ROGERS, LISA; MARTAKOS, PAUL; KARWOSKI, THEODORE; HERWECK, STEVE A.; FAUCHER, KEITH; SWANICK, THOMAS M.
To: ATRIUM MEDICAL CORPORATION
Reel/Frame 017098/0897 →
Continuity (2)
Provisional Application 60613808 · Sep 28, 2004
Related Publication 20060067975A1 · Mar 30, 2006